An oncology drug trial halted after a patient death most captured the attention of readers in September.
Here are the 10 most-read supply chain stories for September, starting with the most popular.
1. Patient death spurs FDA to halt cancer drug trials
2. Amazon in talks with PBMs over pharma supply chain
3. FDA: Major drug shortages possible after Hurricane Maria
4. 6 FDA decisions to look for in September
5. How this movie studio is challenging blood draw restrictions
6. Cleveland Clinic's 5-step strategy to address rising drug prices
7. Supply chain inefficiencies leave $23B in potential savings on the table for hospitals
8. FDA calls out EpiPen manufacturer for product flaws linked to patient deaths
9. Hurricane Maria stalls shipments of Baxter's IV products to US hospitals
10. Express Scripts CMO: Healthcare system isn't set up to pay for Novartis' $475k cancer drug